Cargando…

Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm

Detalles Bibliográficos
Autores principales: González-Nicolás, María Ángeles, González-Guerrero, Cristian, Pérez-Fernández, Verónica Astrid, Lázaro, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543365/
https://www.ncbi.nlm.nih.gov/pubmed/33117530
http://dx.doi.org/10.1093/ckj/sfaa193
_version_ 1783591693863354368
author González-Nicolás, María Ángeles
González-Guerrero, Cristian
Pérez-Fernández, Verónica Astrid
Lázaro, Alberto
author_facet González-Nicolás, María Ángeles
González-Guerrero, Cristian
Pérez-Fernández, Verónica Astrid
Lázaro, Alberto
author_sort González-Nicolás, María Ángeles
collection PubMed
description
format Online
Article
Text
id pubmed-7543365
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-75433652020-10-08 Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm González-Nicolás, María Ángeles González-Guerrero, Cristian Pérez-Fernández, Verónica Astrid Lázaro, Alberto Clin Kidney J Letters to the Editor Oxford University Press 2020-09-24 /pmc/articles/PMC7543365/ /pubmed/33117530 http://dx.doi.org/10.1093/ckj/sfaa193 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letters to the Editor
González-Nicolás, María Ángeles
González-Guerrero, Cristian
Pérez-Fernández, Verónica Astrid
Lázaro, Alberto
Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
title Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
title_full Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
title_fullStr Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
title_full_unstemmed Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
title_short Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm
title_sort cilastatin: a potential treatment strategy against covid-19 that may decrease viral replication and protect from the cytokine storm
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543365/
https://www.ncbi.nlm.nih.gov/pubmed/33117530
http://dx.doi.org/10.1093/ckj/sfaa193
work_keys_str_mv AT gonzaleznicolasmariaangeles cilastatinapotentialtreatmentstrategyagainstcovid19thatmaydecreaseviralreplicationandprotectfromthecytokinestorm
AT gonzalezguerrerocristian cilastatinapotentialtreatmentstrategyagainstcovid19thatmaydecreaseviralreplicationandprotectfromthecytokinestorm
AT perezfernandezveronicaastrid cilastatinapotentialtreatmentstrategyagainstcovid19thatmaydecreaseviralreplicationandprotectfromthecytokinestorm
AT lazaroalberto cilastatinapotentialtreatmentstrategyagainstcovid19thatmaydecreaseviralreplicationandprotectfromthecytokinestorm